Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 3:10:869628.
doi: 10.3389/fped.2022.869628. eCollection 2022.

The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft

Affiliations
Review

The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft

Paul Luchian Aldea et al. Front Pediatr. .

Abstract

Kidney transplantation (KT) is currently the elective approach for patients with end-stage renal disease. Although it is a safe choice for these patients, the early complications can lead to graft dysfunction. One of the most redoubtable complications is delayed graft function (DGF), having no specific treatment. The effects of DGF on the graft survival are large enough to justify the formulation of specific biological protocols. Therefore, discovering biomarkers of acute impairment in renal transplanted patients is required. Creatinine is a poor marker to establish the kidney injury. Estimated glomerular filtration rate together with creatinine is ready to approximately measure the kidney function. Different serum and urine proteins are being studied as possible predictive biomarkers for delayed graft function. This review will concentrate on recent and existing research which provide insight concerning the contribution of some molecules for the estimation and evaluation of graft function after kidney transplantation. Further studies examining various aspects of DGF after KT are urgently needed to address a hitherto less-known clinical question.

Keywords: beta 2 microglobulin; biomarkers; cystatin C; graft function; kidney injury molecule 1; neutrophil gelatinase-related lipoprotein.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Traditional and new biomarkers that can indicate kidney damage.

References

    1. Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant. (2010) 10:2279–86. 10.1111/j.1600-6143.2010.03179.x - DOI - PubMed
    1. Matas AJ, Smith JM, Skeans MA, Thompson B, Gustafson SK, Stewart DE, et al. . OPTN/SRTR. 2013 annual data report: kidney. Am J Transplant. (2015) 15:1–34. 10.1111/ajt.13195 - DOI - PubMed
    1. Yarlagadda SG, Coca SG, Garg AX, Doshi M, Poggio E, Marcus RJ, et al. . Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant. (2008) 23:2995–3003. 10.1093/ndt/gfn158 - DOI - PMC - PubMed
    1. Helfer MS, Pompeo JC, Costa ORS, Vicari AR, Ribeiro AR, Manfro RC. Long-term effects of delayed graft function duration on function and survival of deceased donor kidney transplants. J Bras Nefrol. (2019) 41:231–41. 10.1590/2175-8239-jbn-2018-0065 - DOI - PMC - PubMed
    1. Redfield RR, Scalea JR, Zens TJ. Predictors and outcomes of delayed graft function after living-donor kidney transplantation. Transplant Int. (2015) 29:81–7. 10.1111/tri.12696 - DOI - PubMed